Medicare Enrolled

Dr. Jose Martinez, MD

Ophthalmology · Austin, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
801 W 38TH ST, Austin, TX 78705
5124510103
In practice since 2006 (20 years)
NPI: 1679545370 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Martinez from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Martinez? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Martinez

Dr. Jose Martinez is an ophthalmology specialist in Austin, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Martinez performed 20,534 Medicare services across 3,665 unique beneficiaries.

Between the years covered by Open Payments, Dr. Martinez received a total of $40,167 from 23 pharmaceutical and/or device companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in ophthalmology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Martinez is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in TX $40,167 industry payments

Medicare Practice Summary

Medicare Utilization ↗
20,534
Medicare services
Top 5% in TX for ophthalmology
3,665
Unique beneficiaries
$185
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,027 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
8,041 $29 $84
Aflibercept eye injection (Eylea) 2,768 $692 $2,000
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,369 $30 $125
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
2,101 $120 $336
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,733 $101 $550
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
648 $65 $200
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
557 $212 $1,000
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
450 $89 $265
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
421 $108 $270
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
417 $1,920 $5,262
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
350 $27 $95
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
173 $92 $270
Injection, ranibizumab, 0.1 mg 137 $180 $859
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
117 $107 $315
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
92 $72 $190
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
68 $54 $150
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
43 $116 $350
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
32 $38 $150
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
17 $885 $2,310
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$40,167
Total received (2018-2024)
Avg $5,738/year across 7 years
Top 6% in TX for ophthalmology
23
Companies
84
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$35,376 (88.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,731 (6.8%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$1,560 (3.9%)
Scientific / Research
Research funding and grants
$500 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$14,109
2023
$4,639
2022
$7,394
2021
$7,642
2020
$4,998
2019
$1,061
2018
$324

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Regeneron Healthcare Solutions, Inc.
$35,401
US Retina LLC
$1,560
Regeneron Pharmaceuticals, Inc.
$795
ABBVIE INC.
$515
Genentech USA, Inc.
$332
Aerie Pharmaceuticals, Inc.
$240
TissueTech, Inc.
$205
Carl Zeiss Meditec, Inc.
$176
Mallinckrodt Enterprises LLC
$119
AbbVie, Inc.
$110
Mallinckrodt Hospital Products Inc.
$109
Genentech, Inc.
$107
Apellis Pharmaceuticals, Inc.
$83
EyePoint Pharmaceuticals US, Inc.
$80
Astellas Pharma US Inc
$65
Biogen, Inc.
$60
Bausch & Lomb Americas Inc.
$48
Heidelberg Engineering, Inc.
$43
Novartis Pharmaceuticals Corporation
$39
Alimera Sciences, Inc.
$32
Sun Pharmaceutical Industries Inc.
$25
GlaxoSmithKline, LLC.
$12
Retrophin, Inc.
$11
Top 3 companies account for 94.0% of total payments
Associated products mentioned in payments ›
(820) Cholbam · ACTHAR · BEOVU · BYOOVIZ · BromSite (bromfenac ophthalmic solution) 0.075% · CLARUS · DEXYCU · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Humira · ILUVIEN · Izervay · Lucentis · OZURDEX · Prokera · Rhopressa · Rituxan · Spectralis · Syfovre · TRELEGY ELLIPTA · VABYSMO · Vabysmo · XIPERE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (88%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in ophthalmology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for ophthalmology in TX.

Equivalent to $196 per 100 Medicare services performed
Looking for an ophthalmology specialist in Austin?
Compare ophthalmologists in the Austin area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists within 10 mi
133
Per 100K population
10.2
County median income
$97,169
Nearest hospital
ASCENSION SETON MEDICAL CENTER AUSTIN
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Martinez is a mixed practice specialist, with above-average Medicare volume (top 5% in TX), with speaking/promotional industry engagement in the top 6% of TX peers, with 20 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Martinez experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Martinez performed 8,041 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Martinez receive payments from pharmaceutical companies?
Yes. Dr. Martinez received a total of $40,167 from 23 companies across 84 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Martinez's costs compare to other ophthalmologists in Austin?
Dr. Martinez's average Medicare payment per service is $185. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Martinez) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →